Photo tsaken from Samarpana Chakraborty/X
Aug 10, 2024, 13:03
Samarpana Chakraborty: STAT3 degraders in Venetoclax resistant AML
Samarpana Chakraborty, Postdoctoral Researcher at Albert Einstein College of Medicine shared a post by Aditi Shastri, Associate Professor at Albert Einstein College of Medicine on X:
“Thrilled to share my postdoctoral work on STAT3 degraders in Venetoclax resistant AML. Grateful to Shastri lab and Aditi Shastri for giving me the opportunity to work on this fantastic project. ”
Quoting Aditi Shastri’s post:
“A new manuscript from shastri lab just dropped “A STAT3 Degrader Demonstrates Preclinical Efficacy in Venetoclax Resistant AML”. Congratulations to first author Samarpana Chakraborty and a huge thanks to amazing collabs and Kymera Therapeutics, EinsteinSCI, and Montefiore Health System.”
Source: Samarpana Chakraborty/X and Aditi Shastri/X
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 8, 2025, 16:46
Aug 8, 2025, 16:41
Aug 8, 2025, 16:31
Aug 8, 2025, 16:11
Aug 8, 2025, 15:57
Aug 8, 2025, 15:54
Aug 8, 2025, 15:49